Linda Härmark
Impact in
- Toxicology top 0.05%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 37
- Pharmacovigilance and Adverse Drug Reactions 37
-
- Drug-Induced Adverse Reactions 6
- Pharmaceutical industry and healthcare 4
- Co-authors
- A.C. van Grootheest (4 shared papers)Florence van Hunsel (12 shared papers)Kees van Grootheest (10 shared papers)Eugène van Puijenbroek (13 shared papers)Birgitta Grundmark (2 shared papers)Sten Olsson (1 shared paper)Shanthi Pal (1 shared paper)H.E. van der Wiel (1 shared paper)
- Journals
- Drug Safety (17 papers)Pharmacoepidemiology and Drug Safety (6 papers)European Journal of Clinical Pharmacology (5 papers)Expert Opinion on Drug Safety (5 papers)Vaccine (3 papers)
- Partner nations
- NetherlandsSwedenSwitzerland
In The Last Decade
Linda Härmark
57 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 111
- Toxicology 768
- Geriatrics and Gerontology 62
- Pharmacology 158
- Pharmacology 82
- Pediatrics, Perinatology and Child Health 154
Countries citing papers authored by Linda Härmark
This map shows the geographic impact of Linda Härmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Härmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Härmark more than expected).
Fields of papers citing papers by Linda Härmark
This network shows the impact of papers produced by Linda Härmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Härmark. The network helps show where Linda Härmark may publish in the future.
Co-authors
The 25 scholars most cited alongside Linda Härmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 205 | |
| 2 | 2011 | 113 | |
| 3 | 2009 | 85 | |
| 4 | 2007 | 80 | |
| 5 | 2015 | 59 | |
| 6 | 2016 | 53 | |
| 7 | 2018 | 50 | |
| 8 | 2005 | 47 | |
| 9 | 2014 | 44 | |
| 10 | 2019 | 42 | |
| 11 | 2017 | 38 | |
| 12 | 2016 | 36 | |
| 13 | 2002 | 34 | |
| 14 | 2017 | 33 | |
| 15 | 2011 | 32 | |
| 16 | 2017 | 30 | |
| 17 | 2016 | 28 | |
| 18 | 2011 | 27 | |
| 19 | 2011 | 27 | |
| 20 | 2011 | 26 |
About Linda Härmark
Linda Härmark is a scholar working on Toxicology, Pharmacology, Pediatrics, Perinatology and Child Health, Pharmacology and Epidemiology, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (37 papers), Drug-Induced Adverse Reactions (6 papers), Pharmaceutical studies and practices (5 papers), Pharmaceutical industry and healthcare (4 papers), Pharmaceutical Economics and Policy (2 papers), Pregnancy and Medication Impact (2 papers), Academic integrity and plagiarism (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Toxicology (768 citations), Geriatrics and Gerontology (62 citations), Pharmacology (158 citations), Pharmacology (82 citations) and Pediatrics, Perinatology and Child Health (154 citations). Linda Härmark has collaborated with scholars based in Netherlands, Sweden and Switzerland. Frequent co-authors include A.C. van Grootheest, Florence van Hunsel, Kees van Grootheest, Eugène van Puijenbroek, Birgitta Grundmark, Sten Olsson, Shanthi Pal, H.E. van der Wiel, Mark de Groot and Leàn Rolfes. Their work appears in journals such as Drug Safety, Pharmacoepidemiology and Drug Safety, European Journal of Clinical Pharmacology, Expert Opinion on Drug Safety and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.